Ninety One North America, Inc. Idexx Laboratories Inc Transaction History

Ninety One North America, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	SELL	$468.04 - $548.53 $366,007 - $428,950	-782 Reduced 6.1%	12,036 $5.86 Million
Q1 2024 Apr 25, 2024	BUY	$515.08 - $576.87 $476,964 - $534,181	926 Added 7.79%	12,818 $6.92 Million
Q4 2023 Jan 31, 2024	BUY	$391.37 - $557.56 $1.98 Million - $2.82 Million	5,063 Added 74.14%	11,892 $6.6 Million
Q3 2023 Oct 10, 2023	SELL	$432.42 - $556.67 $17,729 - $22,823	-41 Reduced 0.6%	6,829 $2.99 Million
Q2 2023 Jul 19, 2023	BUY	$450.7 - $503.61 $68,506 - $76,548	152 Added 2.26%	6,870 $3.45 Million
Q1 2023 Apr 28, 2023	BUY	$406.01 - $514.59 $97,848 - $124,016	241 Added 3.72%	6,718 $3.36 Million
Q4 2022 Feb 07, 2023	BUY	$324.64 - $441.27 $2.1 Million - $2.86 Million	6,477 New	6,477 $2.64 Million

1,212

72.5M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.3B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Ninety One North America, Inc., based on Form 13F filings with the SEC.

Stay updated on Ninety One North America, Inc. with notifications on news.